346 related articles for article (PubMed ID: 11747312)
1. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases.
Ramaha A; Patston PA
Arch Biochem Biophys; 2002 Jan; 397(1):77-83. PubMed ID: 11747312
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II generation at the cell surface of activated neutrophils: novel cathepsin G-mediated catalytic activity that is resistant to inhibition.
Owen CA; Campbell EJ
J Immunol; 1998 Feb; 160(3):1436-43. PubMed ID: 9570564
[TBL] [Abstract][Full Text] [Related]
3. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cystatin C activity by serine proteinases.
Abrahamson M; Buttle DJ; Mason RW; Hansson H; Grubb A; Lilja H; Ohlsson K
Biomed Biochim Acta; 1991; 50(4-6):587-93. PubMed ID: 1801727
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin.
Boudier C; Cadène M; Bieth JG
Biochemistry; 1999 Jun; 38(26):8451-7. PubMed ID: 10387091
[TBL] [Abstract][Full Text] [Related]
7. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases.
Salvesen G; Enghild JJ
Biomed Biochim Acta; 1991; 50(4-6):665-71. PubMed ID: 1801740
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
9. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases.
Owen CA; Campbell MA; Sannes PL; Boukedes SS; Campbell EJ
J Cell Biol; 1995 Nov; 131(3):775-89. PubMed ID: 7593196
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in cathepsin C in two families with Papillon-Lefèvre syndrome are associated with deficiency of serine proteinases in PMNs.
de Haar SF; Jansen DC; Schoenmaker T; De Vree H; Everts V; Beertsen W
Hum Mutat; 2004 May; 23(5):524. PubMed ID: 15108292
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
12. Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G.
Speer CP; Pabst MJ; Hedegaard HB; Rest RF; Johnston RB
J Immunol; 1984 Oct; 133(4):2151-6. PubMed ID: 6088632
[TBL] [Abstract][Full Text] [Related]
13. Change of elastase and cathepsin G content in polymorphonuclear leukocytes during hemodialysis.
Schaefer RM; Herfs N; Ormanns W; Hörl WH; Heidland A
Clin Nephrol; 1988 Jun; 29(6):307-11. PubMed ID: 3396234
[TBL] [Abstract][Full Text] [Related]
14. Amino acid-derived phthalimide and saccharin derivatives as inhibitors of human leukocyte elastase, cathepsin G, and proteinase 3.
Groutas WC; Chong LS; Venkataraman R; Kuang R; Epp JB; Houser-Archield N; Huang H; Hoidal JR
Arch Biochem Biophys; 1996 Aug; 332(2):335-40. PubMed ID: 8806743
[TBL] [Abstract][Full Text] [Related]
15. Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates.
Attucci S; Korkmaz B; Juliano L; Hazouard E; Girardin C; Brillard-Bourdet M; Réhault S; Anthonioz P; Gauthier F
Biochem J; 2002 Sep; 366(Pt 3):965-70. PubMed ID: 12088507
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural changes of the skin induced by human leukocyte elastase and cathepsin G.
Glinski W; Kuligowski M; Pierozynska-Dubowska M; Glinska-Ferenz M; Jablonska S
Acta Derm Venereol; 1991; 71(4):277-82. PubMed ID: 1681641
[TBL] [Abstract][Full Text] [Related]
18. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
19. Progressive inactivation of cathepsin G and elastase released from activated neutrophils in vitro: lack of participation of the neutrophil alpha 1-proteinase inhibitor.
Renesto P; Chignard M
J Lab Clin Med; 1994 Jun; 123(6):906-13. PubMed ID: 8201270
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.
Döring G; Frank F; Boudier C; Herbert S; Fleischer B; Bellon G
J Immunol; 1995 May; 154(9):4842-50. PubMed ID: 7722333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
